Drugs / AC105
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01750684 Comparator | Jul 2013 → Feb 2015 | spinal cord injury | Acorda Therapeutics | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AC105 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01750684 ↗ |
| Route | Intravenous | “6 intravenous doses over 30 hours” NCT01750684 ↗ |